1-(2-((2-(piperazin-1-yl)ethyl)amino)benzyl)-5-(trifluoromethyl)pyridin-2(1H)-one

ID: ALA4791305

PubChem CID: 49822133

Max Phase: Preclinical

Molecular Formula: C19H23F3N4O

Molecular Weight: 380.41

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=c1ccc(C(F)(F)F)cn1Cc1ccccc1NCCN1CCNCC1

Standard InChI:  InChI=1S/C19H23F3N4O/c20-19(21,22)16-5-6-18(27)26(14-16)13-15-3-1-2-4-17(15)24-9-12-25-10-7-23-8-11-25/h1-6,14,23-24H,7-13H2

Standard InChI Key:  PVZOBZBTBBRLCV-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    7.1015  -25.0192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1004  -25.8388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8084  -26.2477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5181  -25.8383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5153  -25.0156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8067  -24.6104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3937  -24.6108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3935  -23.7936    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6857  -23.3852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1012  -23.3848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6855  -22.5680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1010  -22.5676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3931  -22.1592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8090  -23.7933    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9777  -22.1596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9775  -21.3424    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.2701  -22.5683    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.2676  -21.7505    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.3924  -26.2468    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6850  -25.8376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9770  -26.2457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2696  -25.8365    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5615  -26.2446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2702  -25.0193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8541  -25.8354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5628  -24.6102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8548  -25.0182    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
  9 11  2  0
 10 12  1  0
 11 13  1  0
 12 13  2  0
 10 14  2  0
 11 15  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
  2 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 23 25  1  0
 24 26  1  0
 25 27  1  0
 27 26  1  0
M  END

Associated Targets(non-human)

NIH3T3 (5395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 380.41Molecular Weight (Monoisotopic): 380.1824AlogP: 2.23#Rotatable Bonds: 6
Polar Surface Area: 49.30Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.23CX LogP: 1.53CX LogD: -0.29
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.81Np Likeness Score: -1.79

References

1. Chen J,Peng Z,Lu M,Xiong X,Chen Z,Li Q,Cheng Z,Jiang D,Tao L,Hu G.  (2018)  Discovery of 1-(4-((3-(4-methylpiperazin-1-yl)propyl)amino)benzyl)-5-(trifluoromethyl)pyridin-2(1H)-one, an orally active multi-target agent for the treatment of diabetic nephropathy.,  28  (2): [PMID:29248299] [10.1016/j.bmcl.2017.07.001]

Source